Daryl Faulds
10Patents
5h-index
26Co-inventors
66Inventor score
Filing activity: Jan 20, 1988 → Mar 28, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5240706A | Intranasal administration of Mycoplasma hyopneumoniae antigen | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6025376A | Chiral methylphenyloxazolidinones | Chemistry; Metallurgy | 17 | Expired |
| US5252328A | Mycoplasma hyopneumoniae antigen and uses therefor | Emerging Cross-Sectional Technologies | 14 | Expired |
| US4985243A | Composition and method for protecting against diseases caused by microorganisms | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6117895A | Pharmaceutical preparations for TNF inhibition | Human Necessities | 5 | Expired |
| US8183286B2 | EP2 and EP4 agonists as agents for the treatment of influenza a viral infection | Human Necessities | 3 | Active |
| US8980944B2 | EP2 and EP4 agonists as agents for the treatment of influenza a viral infection | Human Necessities | 1 | Active |
| US7776896B2 | 5-cyano-prostacyclin derivatives as agents for the treatment of influenza a viral infection | Chemistry; Metallurgy | 1 | Active |
| US6475718B2 | Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus | Human Necessities | 1 | Expired |
| US7563924B2 | 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.